What is the timeline for the normal course issuer bid (NCIB) and how quickly can the market expect to see execution? | TRI (Aug 15, 2025) | Candlesense

What is the timeline for the normal course issuer bid (NCIB) and how quickly can the market expect to see execution?

Timeline and execution speed

Thomson Reuters has opened a new Normal Course Issuer Bid (NCIB) that runs for up to 12 months – the standard maximum period allowed under Canadian securities rules. Within that window the company can buy shares on a daily basis, subject to a 1 % of free‑float cap per day (the usual NCIB limit). Because the program is a “normal‑course” bid rather than a accelerated‑‑or‑“open‑market” buy‑back, the company will not be forced to move the entire $1 billion allocation immediately; instead it will accumulate purchases over the year, pacing them to market conditions and available liquidity.

What to expect in the short term

Given the 1 % daily cap and the size of TRI’s free‑float (roughly 200 million shares), the maximum daily volume the issuer can absorb is about 2 million shares. In a typical, moderately liquid U.S.‑/Canadian‑listed stock, that translates to a few hundred thousand to 1 million shares per day in practice, especially when the market is calm. Consequently, most of the buy‑back will be executed gradually over weeks to months rather than in a single burst. Traders can therefore anticipate a steady, upward pressure on the price as the NCIB proceeds, with the most noticeable impact occurring when the company hits its quarterly or semi‑annual purchase milestones (e.g., $100‑$200 million blocks).

Actionable take‑away

  • Short‑term: Expect modest, incremental price support as daily purchases roll out. Look for a tightening of the bid‑ask spread and modest upside in the next 4‑8 weeks, especially if the market absorbs the daily caps without significant resistance.
  • Medium‑term: As the NCIB progresses toward the 12‑month horizon, cumulative buying could become a visible catalyst for a mid‑term rally; watch for price‑level clusters around the $70‑$75 range (current levels) where the company may accelerate purchases to meet its $1 billion target.
  • Risk: If the stock experiences heightened volatility or a sharp down‑trend, the issuer may pause or slow purchases, temporarily dampening the upward bias.

In short, the NCIB will run for up to a year, with daily execution limited to roughly 1 % of free float. The market can therefore expect gradual, sustained buying pressure rather than an immediate, large‑scale execution—providing a clear, but measured, upside catalyst for TRI’s equity over the coming months.